CDTX vs CLOV
Cidara Therapeutics Inc (CDTX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
CDTX currently screens at market cap $6.96B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the CDTX and CLOV stock pages for the full models.
Not investment advice.